The prevalence of neurodegenerative disease (ND) is increasing, partly owing to extensions
in lifespan, with a larger percentage of members living to an older age, but the ND aetiology …

In a literature survey, Chernoff et al.(2017) dismissed the hypothesis that chronic exposure
to β-N-methylamino-L-alanine (BMAA) may be a risk factor for progressive …

Background After decades of research recognizing it as a complex multifactorial disorder,
sporadic Alzheimer's disease (sAD) still has no known etiology. Adding to the myriad of …

The implication of the cyanotoxin β-N-methylamino-l-alanine (BMAA) in long-lasting
neurodegenerative disorders is still a matter of controversy. It has been alleged that chronic …

Of the documented cases of Parkinson's disease (PD), about 10% have a genetic
background. The remaining cases of PD have unknown etiology. Thus, environmental …

The neurotoxin β-N-methylamino-L-alanine (BMAA) reported in some cyanobacteria and
eukaryote microalgae is a cause of concern due to its potential risk of human …

Abstract β-N-methylamino-L-alanine (BMAA) has been shown to accumulate in organisms
by associating with host proteins. It has been proposed that this association is the result of …

Cyanobacteria are photosynthetic microorganisms distributed globally in aquatic and
terrestrial environments. They are also industrially cultivated to be used as dietary …

Aims Brain disease, in its many forms, has recently demonstrated a great socio-economic
impact and represents one of the hardest challenges of present research. Although each …

Abstract β-N-Methylamino-l-alanine (BMAA) is a non-proteinogenic amino acid produced by
cyanobacteria, which has been implicated in several neurodegenerative diseases, including …